Literature DB >> 24011584

Classification of primary hepatic tumours in the dog.

Renee G H M van Sprundel1, Ted S G A M van den Ingh, Franco Guscetti, Olivia Kershaw, Hideyuki Kanemoto, Henrika M van Gils, Jan Rothuizen, Tania Roskams, Bart Spee.   

Abstract

Many advances have been made in the characterisation of primary liver tumours in humans, in particular relating to the identification and role of hepatic progenitor cells, resulting in a new classification. The aim of the present study was to investigate the presence and relative frequency of morphological types of canine primary hepatic neoplasms and to determine whether a classification similar to the human scheme can be applied to these canine neoplasms. Canine primary liver tumours (n=106) were examined histologically and with the immunohistochemical markers keratin 19, HepPar-1, epithelial membrane antigen/mucin-1, CD10, neuron-specific enolase and chromogranin-A. Eleven nodular hyperplasias and 82 tumours of hepatocellular origin were diagnosed. The latter were subdivided in hepatocellular tumours with 0-5% positivity for K19 (n=62), which were well differentiated and had no evidence of metastasis, tumours with >5% positivity for K19 (n=17), which were poorly differentiated and had intrahepatic and/or distant metastasis, and a scirrhous subgroup (n=3) with an intermediate position with regard to K19 staining and malignancy. Ten cholangiocellular tumours (nine cholangiocellular carcinomas and one cholangiolocarcinoma) were diagnosed and all had intrahepatic and/or distant metastases. Three neuroendocrine carcinomas were also diagnosed. Histopathological and immunohistochemical examination of canine primary hepatic neoplasms can differentiate hepatocellular, cholangiocellular and neuroendocrine tumours, in accordance with the most recent human classification system.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Canine; Classification; Immunohistochemistry; Liver tumours

Mesh:

Substances:

Year:  2013        PMID: 24011584     DOI: 10.1016/j.tvjl.2013.05.027

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  8 in total

1.  One What? Why GI Researchers Should Know and Care About the One Health Initiative.

Authors:  Rebecca G Wells
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-09-28

2.  Drug-eluting bead chemoembolization for the treatment of nonresectable hepatic carcinoma in dogs: A prospective clinical trial.

Authors:  Cleo P Rogatko; Chick Weisse; Tobias Schwarz; Allyson C Berent; Marcio A Diniz
Journal:  J Vet Intern Med       Date:  2021-05-06       Impact factor: 3.333

3.  Hepatocellular Carcinoma in a Free-Ranging Three-Toed Sloth (Bradypus variegatus).

Authors:  Alex Junior Souza de Souza; Andreza Pinheiro Malheiros; Victor Lopes da Silva; Tereza Cristina da Silva; Bruno Cogliati; Lilian Rose Marques de Sá
Journal:  Animals (Basel)       Date:  2022-07-28       Impact factor: 3.231

4.  Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case-control study.

Authors:  Janis M Lapsley; Vincent Wavreille; Sabrina Barry; Josephine A Dornbusch; Carolyn Chen; Haley Leeper; Judith Bertran; Diane Scavelli; Julius M Liptak; Chris Wood; Shelly Shamir; Claire Rosenbaum; Vincenzo Montinaro; Brandan Wustefeld-Janssens; Allyson Sterman; Colin Chik; Ameet Singh; Josh Collins; Laura E Selmic
Journal:  Vet Comp Oncol       Date:  2022-05-15       Impact factor: 2.385

Review 5.  Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs.

Authors:  Erin A Gibson; Roger E Goldman; William T N Culp
Journal:  Vet Sci       Date:  2022-09-08

6.  Serum steroid profiling of hepatocellular carcinoma associated with hyperadrenocorticism in dogs: A preliminary study.

Authors:  Thandar Oo; Noboru Sasaki; Yoshinori Ikenaka; Takahiro Ichise; Noriyuki Nagata; Nozomu Yokoyama; Kazuyoshi Sasaoka; Keitaro Morishita; Kensuke Nakamura; Mitsuyoshi Takiguchi
Journal:  Front Vet Sci       Date:  2022-09-28

Review 7.  Hepatic progenitor cells in canine and feline medicine: potential for regenerative strategies.

Authors:  Hedwig S Kruitwagen; Bart Spee; Baukje A Schotanus
Journal:  BMC Vet Res       Date:  2014-06-19       Impact factor: 2.741

8.  Cellular characteristics of keratin 19-positive canine hepatocellular tumours explain its aggressive behaviour.

Authors:  Renee G van Sprundel; Ted Sgam van den Ingh; Baukje A Schotanus; Monique E van Wolferen; Louis C Penning; Jan Rothuizen; Bart Spee
Journal:  Vet Rec Open       Date:  2017-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.